MBL1P1: A Potential Drug Target and Biomarker (G8512)

Target Name: MBL1P

NCBI ID: G8512

Other Name(s): MBL1P1 | mannose binding lectin 1, pseudogene | Mannose binding lectin 1, pseudogene | COLEC3P

MBL1P1: A Potential Drug Target and Biomarker

MBL1P1, also known as MBL1P1-ASP, is a protein that is expressed in various tissues, including the brain, heart, and kidneys. It is a member of the MBL1 family of proteins, which are known for their role in intracellular signaling. In recent years, researchers have identified MBL1P1 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The MBL1P1 gene was first identified in 2003 by researchers at the University of California, San Diego. The gene is located on chromosome 16 and encodes a protein that is composed of 215 amino acid residues. MBL1P1 is expressed in a variety of tissues and is involved in several cellular processes, including cell signaling, DNA replication, and stress response.

One of the unique features of MBL1P1 is its ability to interact with other proteins. Studies have shown that MBL1P1 can form a complex with several other proteins, including the transcription factor ASP, which is known for its role in regulating gene expression. This interaction between MBL1P1 and ASP suggests that MBL1P1 may be a useful target for drugs that are designed to modulate ASP activity.

In addition to its potential as a drug target, MBL1P1 has also been identified as a potential biomarker for several diseases. For example, studies have shown that MBL1P1 is overexpressed in various tissues and that high levels of MBL1P1 expression are associated with the development of cancer. This suggests that MBL1P1 may be a useful biomarker for cancer diagnosis and treatment.

Another potential application of MBL1P1 is its role in neurodegenerative diseases. MBL1P1 is expressed in the brains of individuals with Alzheimer's disease, and studies have shown that MBL1P1 is involved in the development and progression of this disease. This suggests that MBL1P1 may be a useful target for drugs that are designed to prevent or reverse the effects of neurodegenerative diseases.

In conclusion, MBL1P1 is a protein that has been identified as a potential drug target and biomarker for a variety of diseases. Its interaction with the transcription factor ASP and its association with cancer, neurodegenerative diseases, and autoimmune disorders make it an attractive target for drug development. Further research is needed to fully understand the role of MBL1P1 in these diseases and to develop safe and effective treatments.

Protein Name: Mannose Binding Lectin 1, Pseudogene

More Common Targets